Letter to the Editor
Bone Marrow Transplantation (2007) 39, 653–654. doi:10.1038/sj.bmt.1705659; published online 26 March 2007
Posterior reversible encephalopathy syndrome due to sirolimus
A Moskowitz1, C Nolan2, E Lis3, H Castro-Malaspina1 and M-A Perales1
- 1Allogeneic Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
- 2Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
- 3Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Correspondence: M-A Perales, E-mail: peralesm@mskcc.org
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Posterior reversible encephalopathy syndrome due to sirolimus
Bone Marrow Transplantation Letter
Recurrent posterior reversible encephalopathy syndrome (PRES)
Journal of Human Hypertension Correspondence
